Skip to main content
ConductScienceScienceDex

Vassiliki A Boussiotis

NIH Rank #5771
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2206318Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#5,771
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Vassiliki A Boussiotis. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Vassiliki A Boussiotis as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA257672-02R01
    Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapy
    Beth Israel Deaconess Medical Center
    $676K
    award amount
  • 5R01CA238263-05R01
    The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunity
    Beth Israel Deaconess Medical Center
    $623.1K
    award amount
  • 5R01CA271601-02R01
    Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.
    Beth Israel Deaconess Medical Center
    $618.8K
    award amount

Award organization

Organizations that administered FY2024 awards listing Vassiliki A Boussiotis as a PI.

FY2024 award administered by Beth Israel Deaconess Medical Center (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Beth Israel Deaconess Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5771
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Entered Top 25% Nationally
    Ranked #3626
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding
  9. 2026
    Entered Top 10% Nationally
    Ranked #1625

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Vassiliki A Boussiotis.

Alain Charest
Beth Israel Deaconess Medical Center
5
shared awards
Ioannis Vlachos
Beth Israel Deaconess Medical Center
3
shared awards
Roel Gw Verhaak
Beth Israel Deaconess Medical Center
3
shared awards
Sizun Jiang
Beth Israel Deaconess Medical Center
2
shared awards

Explore further

Find collaborators for Vassiliki A Boussiotis

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →